These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 2295674
21. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival. Hung GY, Yen HJ, Yen CC, Chen WM, Chen PC, Wu HT, Chiou HJ, Chang WH, Hsu HE. Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470 [Abstract] [Full Text] [Related]
22. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors]. Ham SJ, Kroon HM, Schraffordt Koops H, Hoekstra HJ. Ned Tijdschr Geneeskd; 2000 Jan 15; 144(3):121-5. PubMed ID: 10674118 [Abstract] [Full Text] [Related]
24. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study. Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS. Pediatr Blood Cancer; 2014 May 15; 61(5):840-5. PubMed ID: 24254749 [Abstract] [Full Text] [Related]
25. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response. Lewis VO, Raymond K, Mirza AN, Lin P, Yasko AW. Clin Orthop Relat Res; 2006 Sep 15; 450():60-6. PubMed ID: 16906104 [Abstract] [Full Text] [Related]
26. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients. Kim W, Han I, Lee JS, Cho HS, Park JW, Kim HS. J Surg Oncol; 2018 May 15; 117(6):1223-1231. PubMed ID: 29409122 [Abstract] [Full Text] [Related]
27. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma. Jeon DG, Kong CB, Cho WH, Song WS, Cho SH, Choi SW, Lee SY. J Surg Oncol; 2014 Mar 15; 109(3):275-9. PubMed ID: 24243222 [Abstract] [Full Text] [Related]
28. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. Ferrari S, Briccoli A, Mercuri M, Bertoni F, Picci P, Tienghi A, Del Prever AB, Fagioli F, Comandone A, Bacci G. J Clin Oncol; 2003 Feb 15; 21(4):710-5. PubMed ID: 12586810 [Abstract] [Full Text] [Related]
29. A new relative tumor sizing method in epi-metaphyseal osteosarcoma. Kim SH, Shin KH, Park EH, Cho YJ, Park BK, Suh JS, Yang WI. BMC Cancer; 2015 Apr 15; 15():284. PubMed ID: 25885468 [Abstract] [Full Text] [Related]
30. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma. Zhu Y, Zhou J, Ji Y, Yu B. Mol Med Rep; 2014 Aug 15; 10(2):737-42. PubMed ID: 24919955 [Abstract] [Full Text] [Related]
31. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Bacci G, Longhi A, Cesari M, Versari M, Bertoni F. Cancer; 2006 Jun 15; 106(12):2701-6. PubMed ID: 16691623 [Abstract] [Full Text] [Related]
32. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases. Iwata S, Ishii T, Kawai A, Hiruma T, Yonemoto T, Kamoda H, Asano N, Takeyama M. Ann Surg Oncol; 2014 Jan 15; 21(1):263-8. PubMed ID: 23975321 [Abstract] [Full Text] [Related]
33. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group. J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156 [Abstract] [Full Text] [Related]
34. [Osteosarcoma lung metastases. Survival after chemotherapy and surgery]. Farfalli GL, Albergo JI, Lobos PA, Smith DE, Streitenberger PD, Pallotta Rodríguez MG, Aponte-Tinao LA. Medicina (B Aires); 2015 May 15; 75(2):87-90. PubMed ID: 25919869 [Abstract] [Full Text] [Related]
35. Caffeine-potentiated chemotherapy for metastatic osteosarcoma. Kimura H, Tsuchiya H, Shirai T, Nishida H, Hayashi K, Takeuchi A, Ohnari I, Tomita K. J Orthop Sci; 2009 Sep 15; 14(5):556-65. PubMed ID: 19802667 [Abstract] [Full Text] [Related]
36. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy]. Zhang Q, Niu XH, Cai YB, Hao L, Ding Y. Zhonghua Wai Ke Za Zhi; 2007 Aug 15; 45(16):1114-7. PubMed ID: 18005614 [Abstract] [Full Text] [Related]
37. Worse prognosis of osteosarcoma patients expressing IGF-1 on a tissue microarray. Jentzsch T, Robl B, Husmann M, Bode-Lesniewska B, Fuchs B. Anticancer Res; 2014 Aug 15; 34(8):3881-9. PubMed ID: 25075009 [Abstract] [Full Text] [Related]
38. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, Higashino F, Mezawa F, Okada F, Ishii S. Clin Cancer Res; 2000 Feb 15; 6(2):572-7. PubMed ID: 10690541 [Abstract] [Full Text] [Related]
39. The incidence of skip metastases on whole bone MRI in high-grade bone sarcomas. Saifuddin A, Sharif B, Oliveira I, Kalus S, Barnett J, Pressney I. Skeletal Radiol; 2020 Jun 15; 49(6):945-954. PubMed ID: 31919587 [Abstract] [Full Text] [Related]
40. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. Simon MA, Aschliman MA, Thomas N, Mankin HJ. J Bone Joint Surg Am; 1986 Dec 15; 68(9):1331-7. PubMed ID: 3465732 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]